SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, Inc., one of the leading providers of advanced technologies and outsourced services to the global pharmaceutical, biotechnology and consumer health industry announced its financial results for the first quarter ended September 30, 2007. Catalent recognized net revenue for the three months then ended of $438.0 million, and EBITDA from continuing operations of $57.8 million for the same period after giving effect to the Acquisition and related purchase method of accounting adjustments. Adjusted EBITDA as detailed in the attached schedules for the twelve months ended September 30, 2007 was $339.1 million. EBITDA and adjusted EBITDA are defined below under “Non-GAAP Financial Matters”.
